SILENCING OF HUMAN-IMMUNODEFICIENCY-VIRUS LONG TERMINAL REPEAT EXPRESSION BY AN ADENOVIRUS-E1A MUTANT

被引:28
作者
VENTURA, AM
ARENS, MQ
SRINIVASAN, A
CHINNADURAI, G
机构
[1] ST LOUIS UNIV,SCH MED,INST MOLEC VIROL,3681 PK AVE,ST LOUIS,MO 63110
[2] WASHINGTON UNIV,SCH MED,DEPT PEDIAT,ST LOUIS,MO 63110
[3] WISTAR INST,PHILADELPHIA,PA 19104
关键词
Enhancer repression; Human immunodeficiency virus inhibition; Trans-activation;
D O I
10.1073/pnas.87.4.1310
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Gene expression from the human immunodeficiency virus (HIV) long terminal repeat (LTR) is strongly stimulated by the viral tat gene. The HIV LTR is also activated by several physical and chemical agents and heterologous viral genes, including adenovirus E1a. As E1a has separable transcriptional activation and repression functions, we examined the negative regulatory effects of E1a on the expression of the HIV LTR by using a trans-dominant E1a mutant. Mutant hr5 strongly suppressed the basal activity of the LTR as well as trans-activation of the LTR by heterologous agents such as the cytomegalovirus immediate early gene or DNA-damaging agents such as mitomycin C and UV irradiation. In addition, hr5 also caused significant suppression of tat gene-mediated trans-activation. The suppression of HIV LTR expression by hr5 appears to be mediated, at least in part, by the repression of the HIV enhancer, as the activity of an enhancer test system composed of the human T-cell leukemia virus I LTR containing an HIV-1 enhancer substitution was severely repressed by hr5. Cotransfection of HIV-1 proviral DNA with hr5 DNA resulted in a significant reduction of HIV production.
引用
收藏
页码:1310 / 1314
页数:5
相关论文
共 48 条
[1]   TRANS-ACTIVATOR GENE OF HUMAN T-LYMPHOTROPIC VIRUS TYPE-III (HTLV-III) [J].
ARYA, SK ;
GUO, C ;
JOSEPHS, SF ;
WONGSTAAL, F .
SCIENCE, 1985, 229 (4708) :69-73
[2]   I-KAPPA-B - A SPECIFIC INHIBITOR OF THE NF-KAPPA-B TRANSCRIPTION FACTOR [J].
BAEUERLE, PA ;
BALTIMORE, D .
SCIENCE, 1988, 242 (4878) :540-546
[3]   ADENOVIRUS PROMOTERS AND E1A TRANSACTIVATION [J].
BERK, AJ .
ANNUAL REVIEW OF GENETICS, 1986, 20 :45-79
[4]  
BOHAN C, 1990, IN PRESS J VIROL
[5]   ADENOVIRUS-2 E1A PRODUCTS REPRESS ENHANCER-INDUCED STIMULATION OF TRANSCRIPTION [J].
BORRELLI, E ;
HEN, R ;
CHAMBON, P .
NATURE, 1984, 312 (5995) :608-612
[6]   FUNCTIONAL RELATION BETWEEN HTLV-II-X AND ADENOVIRUS-E1A PROTEINS IN TRANSCRIPTIONAL ACTIVATION [J].
CHEN, ISY ;
CANN, AJ ;
SHAH, NP ;
GAYNOR, RB .
SCIENCE, 1985, 230 (4725) :570-573
[7]   IDENTIFICATION AND PURIFICATION OF EBP1 - A HELA-CELL PROTEIN THAT BINDS TO A REGION OVERLAPPING THE CORE OF THE SV40 ENHANCER [J].
CLARK, L ;
POLLOCK, RM ;
HAY, RT .
GENES & DEVELOPMENT, 1988, 2 (08) :991-1002
[8]   INVITRO ACTIVATION OF THE HIV-1 ENHANCER IN EXTRACTS FROM CELLS TREATED WITH A PHORBOL ESTER TUMOR PROMOTER [J].
DINTER, H ;
CHIU, R ;
IMAGAWA, M ;
KARIN, M ;
JONES, KA .
EMBO JOURNAL, 1987, 6 (13) :4067-4071
[9]   THE TRANSACTIVATOR GENE OF HTLV-III IS ESSENTIAL FOR VIRUS-REPLICATION [J].
FISHER, AG ;
FEINBERG, MB ;
JOSEPHS, SF ;
HARPER, ME ;
MARSELLE, LM ;
REYES, G ;
GONDA, MA ;
ALDOVINI, A ;
DEBOUK, C ;
GALLO, RC ;
WONGSTAAL, F .
NATURE, 1986, 320 (6060) :367-371
[10]   A TRANSCRIPTIONAL ENHANCER SEQUENCE OF HTLV-I IS RESPONSIBLE FOR TRANSACTIVATION MEDIATED BY P40X OF HTLV-I [J].
FUJISAWA, J ;
SEIKI, M ;
SATO, M ;
YOSHIDA, M .
EMBO JOURNAL, 1986, 5 (04) :713-718